117 related articles for article (PubMed ID: 7116665)
1. Inhibition of DOC-salt and adrenal-regeneration hypertension with the calcium blocker nifedipine.
Hall CE; Hungerford S
Clin Exp Hypertens A; 1982; 4(7):1217-30. PubMed ID: 7116665
[TBL] [Abstract][Full Text] [Related]
2. Different antihypertensive effects of nifedipine in conscious experimental hypertensive and normotensive rats.
Ishii H; Itoh K; Nose T
Eur J Pharmacol; 1980 May; 64(1):21-9. PubMed ID: 7449813
[TBL] [Abstract][Full Text] [Related]
3. Effects of adrenalectomy and nephrectomy on adrenal regeneration hypertension in the rat.
Chan JY; Chan SH
Proc Natl Sci Counc Repub China B; 1991 Oct; 15(4):197-205. PubMed ID: 1815260
[TBL] [Abstract][Full Text] [Related]
4. [Anti-hypertensive activity of P0285 and nifedipine in conscious normotensive rats and in rats with spontaneous, renal and desoxycorticosterone acetate-induced hypertension].
Marchini F; Luca C; Valli L; Pacei E
Cardiologia; 1987 Jul; 32(7):659-62. PubMed ID: 3690590
[No Abstract] [Full Text] [Related]
5. Antihypertensive effect of KB-944, a new calcium antagonist, in conscious normotensive and hypertensive rats.
Morita T; Kanazawa T; Ito K; Nose T
Arzneimittelforschung; 1982; 32(9):1047-52. PubMed ID: 6890824
[TBL] [Abstract][Full Text] [Related]
6. Prevention of DOCA-salt hypertension with the calcium blocker nitrendipine.
Hall CE; Hungerford S
Clin Exp Hypertens A; 1983; 5(5):721-8. PubMed ID: 6883741
[TBL] [Abstract][Full Text] [Related]
7. Influence of the sympathetic nervous system and vasopressin on the blood pressure lowering effect of nifedipine in deoxycorticosterone acetate-salt hypertensive rats.
Takata Y; Yamashita Y; Takishita S; Fujishima M
Clin Sci (Lond); 1987 Sep; 73(3):253-8. PubMed ID: 3652632
[TBL] [Abstract][Full Text] [Related]
8. Exchangeable sodium in DOC-salt and post-DOC-salt hypertension in rats.
McAreavey D; Brown WB; Murray GD; Robertson JI
J Hypertens; 1985 Jun; 3(3):275-9. PubMed ID: 3894516
[TBL] [Abstract][Full Text] [Related]
9. Renal nerves are not necessary for onset or maintenance of DOC-salt hypertension in rats.
Dzielak DJ; Norman RA
Am J Physiol; 1985 Nov; 249(5 Pt 2):H945-9. PubMed ID: 4061671
[TBL] [Abstract][Full Text] [Related]
10. A study on the effects of nifedipine in hypertensive crises and severe hypertension.
Kuwajima I; Ueda K; Kamata C; Matsushita S; Kuramoto K; Murakami M; Hada Y
Jpn Heart J; 1978 Jul; 19(4):455-67. PubMed ID: 731870
[TBL] [Abstract][Full Text] [Related]
11. Hypertension following adrenal enucleation and its absence during desoxycorticosterone treatment in Long-Evans rats.
Hall CE; Ayachi S; Hall O
Endocrinology; 1973 Apr; 92(4):1175-81. PubMed ID: 4686314
[No Abstract] [Full Text] [Related]
12. Dose-effect relationship in desoxycorticosterone hypertension: reduced sensitivity in adrenalectomized rats and its possible significance to the etiology of adrenal-regeneration hypertension.
Hall CE; Ayachi S
Can J Physiol Pharmacol; 1971 Feb; 49(2):139-46. PubMed ID: 5569178
[No Abstract] [Full Text] [Related]
13. Effects of high calcium diet on arterial smooth muscle function and electrolyte balance in mineralocorticoid-salt hypertensive rats.
Arvola P; Ruskoaho H; Pörsti I
Br J Pharmacol; 1993 Apr; 108(4):948-58. PubMed ID: 8485634
[TBL] [Abstract][Full Text] [Related]
14. DOCA-salt treatment decreases serum total calcium but not ionized calcium concentrations in rats.
Takata Y; Yamashita Y; Takishita S; Fujishima M
Am J Hypertens; 1990 Mar; 3(3):237-9. PubMed ID: 2322435
[TBL] [Abstract][Full Text] [Related]
15. Effect of coenzyme Q10 on experimental hypertension in rats and dogs.
Igarashi T; Nakajima Y; Tanaka M; Otake S
J Pharmacol Exp Ther; 1974 Apr; 189(1):149-56. PubMed ID: 4823289
[No Abstract] [Full Text] [Related]
16. Antihypertensive activity of a new calcium channel blocker LF 2.0254, in spontaneously hypertensive rats: a comparison with nifedipine and nicardipine.
Pruneau D; Brown NL
Arch Int Pharmacodyn Ther; 1988; 295():109-24. PubMed ID: 2977540
[TBL] [Abstract][Full Text] [Related]
17. Prevention of hypertensive vasculopathy by nifedipine in salt-loaded Dahl rats.
Luckhaus G; Garthoff B; Kazda S
Arzneimittelforschung; 1982; 32(11):1421-5. PubMed ID: 6891246
[TBL] [Abstract][Full Text] [Related]
18. STEROID BIOSYNTHESIS BY RAT ADRENAL: DURING DEVELOPMENT OF ADRENAL REGENERATION AND DESOXYCORTICOSTERONE ACETATE-INDUCED HYPERTENSION.
SHEPPARD H; MOWLES TF; CHART JJ; RENZI AA; HOWIE N
Endocrinology; 1964 May; 74():762-9. PubMed ID: 14168565
[No Abstract] [Full Text] [Related]
19. Prevention of adrenal regeneration hypertension.
Gallant S
J Clin Endocrinol Metab; 1974 Mar; 38(3):504-7. PubMed ID: 4815180
[No Abstract] [Full Text] [Related]
20. Salt-induced hypertension in the 'Sabra' rat strain: influence of nifedipine treatment.
Garthoff B; Ebsen W; Luckhaus G; Kazda S; Ben-Ishay D
Clin Sci (Lond); 1985 May; 68(5):495-501. PubMed ID: 3884235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
